Venker Eric

CIK 00018019174 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001801917

Recent Transactions

50 trades

Sale
Immunovant, Inc.$IMVT
Common Stock
2026-07-02$38.48/sh−3,092→ 254,280 total
Exercise/Conversion
Immunovant, Inc.$IMVT
Capped Value Appreciation Rights
2026-07-01−92,188→ 1,014,062 total
Exercise/Conversion
Immunovant, Inc.$IMVT
Common Stock
2026-07-01$14.46/sh+92,188→ 344,001 total
Disposition to Issuer
Immunovant, Inc.$IMVT
Common Stock
2026-07-01$38.14/sh−86,629→ 257,372 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-06-24$3.85/sh+200,000→ 1,813,063 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-06-24$33.05/sh−153,766→ 1,659,297 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-06-24−200,000→ 4,244,834 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-06-24$33.51/sh−46,234→ 1,613,063 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-05-22−200,000→ 4,444,834 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-05-22$30.27/sh−200,000→ 1,613,063 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-05-22$3.85/sh+200,000→ 1,813,063 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2026-05-20$32.41/sh−34,483→ 1,613,063 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-04-20−200,000→ 4,644,834 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-04-20$29.59/sh−200,000→ 1,647,546 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-04-20$3.85/sh+200,000→ 1,847,546 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2026-04-07+336,043→ 336,043 total
Award
Immunovant, Inc.$IMVT
Common Stock
2026-04-07+232,252→ 251,813 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2026-04-02$24.04/sh−12,820→ 20,970 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2026-04-02$24.60/sh−1,409→ 19,561 total
Exercise/Conversion
Immunovant, Inc.$IMVT
Common Stock
2026-04-01$14.46/sh+368,750→ 368,750 total
Exercise/Conversion
Immunovant, Inc.$IMVT
Capped Value Appreciation Rights
2026-04-01−368,750→ 1,106,250 total
Disposition to Issuer
Immunovant, Inc.$IMVT
Common Stock
2026-04-01$25.10/sh−334,960→ 33,790 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-03-17−200,000→ 4,844,834 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-03-17$3.85/sh+200,000→ 1,847,546 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-03-17$28.24/sh−200,000→ 1,647,546 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-20$27.15/sh−7,051→ 1,647,546 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-13$26.49/sh−200,000→ 1,654,597 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-02-13−200,000→ 5,044,834 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-13$3.85/sh+200,000→ 1,854,597 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-01-12$3.85/sh+200,000→ 1,854,597 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-01-12$21.92/sh−200,000→ 1,654,597 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-01-12−200,000→ 5,244,834 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-09$3.85/sh+200,000→ 1,697,908 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-09$20.85/sh−200,000→ 1,497,908 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-12-09−200,000→ 5,876,523 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-20$20.27/sh−7,051→ 1,497,908 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-11-07$20.22/sh−200,000→ 6,076,523 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-07$3.85/sh+200,000→ 1,704,959 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-07$20.22/sh−200,000→ 1,504,959 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-10-17−118,418→ 0 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-17$15.85/sh+118,418→ 1,623,377 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-17$17.06/sh−118,418→ 1,504,959 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-16$17.05/sh−318,282→ 1,504,959 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-10-16−318,282→ 118,418 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-16$15.85/sh+318,282→ 1,823,241 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-15$15.85/sh+414,683→ 1,919,642 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-15$16.93/sh−414,683→ 1,504,959 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-10-15−414,683→ 436,700 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-10-13$16.25/sh−20,727→ 1,504,959 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-10-13−20,727→ 851,383 total

Companies

Recent Filings

Address

C/O IMMUNOVANT, INC. 1000 PARK FORTY PLAZA, SUITE 210

DURHAM, NC, 27713

View on SEC.gov